Vaccine-induced immune thrombotic thrombocytopenia: Consider IVIG batch in the treatment.
作者信息
Karnam Anupama, Lacroix-Desmazes Sébastien, Kaveri Srini V, Bayry Jagadeesh
机构信息
Centre de Recherché des Cordeliers, Institut National de la Santé et de la Recherche Médicale, Sorbonne Université, Université de Paris, Paris, France.
Indian Institute of Technology Palakkad, Palakkad, India.
出版信息
J Thromb Haemost. 2021 Jul;19(7):1838-1839. doi: 10.1111/jth.15361.
Abstract
摘要
相似文献
1
Vaccine-induced immune thrombotic thrombocytopenia: Consider IVIG batch in the treatment.疫苗诱导的免疫性血栓性血小板减少症：治疗时考虑静脉注射免疫球蛋白批次。
J Thromb Haemost. 2021 Jul;19(7):1838-1839. doi: 10.1111/jth.15361.
2
Dosing of intravenous immunoglobulin in COVID-19 vaccine-induced immune thrombocytopenia and thrombosis.新型冠状病毒肺炎疫苗诱导的免疫性血小板减少症和血栓形成中静脉注射免疫球蛋白的剂量
J Clin Pathol. 2023 Feb;76(2):143-144. doi: 10.1136/jcp-2022-208377. Epub 2022 Sep 29.
3
Vaccine induced immune thrombocytopenia and thrombosis: summary of NICE guidance.疫苗诱导的免疫性血小板减少症和血栓形成：英国国家卫生与临床优化研究所指南摘要
BMJ. 2021 Oct 1;375:n2195. doi: 10.1136/bmj.n2195.
4
Successful treatment of vaccine-induced prothrombotic immune thrombocytopenia (VIPIT).成功治疗疫苗诱导的促血栓形成免疫性血小板减少症（VIPIT）。
J Thromb Haemost. 2021 Jul;19(7):1819-1822. doi: 10.1111/jth.15346. Epub 2021 Jun 11.
5
Cerebral sinus thrombosis following IV immunoglobulin therapy of immune thrombocytopenia purpura.免疫性血小板减少性紫癜患者接受静脉注射免疫球蛋白治疗后发生脑窦血栓形成。
Pediatr Blood Cancer. 2011 Jul 15;57(1):157-9. doi: 10.1002/pbc.22968. Epub 2011 Mar 28.
6
COVID-19 vaccine-induced immune thrombotic thrombocytopenia: A review of the potential mechanisms and proposed management.COVID-19 疫苗诱导的免疫性血栓性血小板减少症：潜在机制的综述及提出的管理建议。
Sci Prog. 2021 Apr-Jun;104(2):368504211025927. doi: 10.1177/00368504211025927.
7
"Vaccine-induced immune thrombotic thrombocytopenia (VITT)-Update on diagnosis and management considering different resources": Comment.“疫苗诱导的免疫性血栓性血小板减少症（VITT）——考虑不同资源的诊断和管理最新进展”：评论
J Thromb Haemost. 2022 Nov;20(11):2707-2708. doi: 10.1111/jth.15853.
8
Treatment of ChAdOx1 nCoV-19 Vaccine-Induced Immune Thrombotic Thrombocytopenia Related Acute Ischemic Stroke.治疗 ChAdOx1 nCoV-19 疫苗诱导的免疫性血栓性血小板减少症相关急性缺血性脑卒中。
J Stroke Cerebrovasc Dis. 2021 Nov;30(11):106072. doi: 10.1016/j.jstrokecerebrovasdis.2021.106072. Epub 2021 Aug 28.
9
Australian and New Zealand approach to diagnosis and management of vaccine-induced immune thrombosis and thrombocytopenia.澳大利亚和新西兰对疫苗诱导的免疫性血栓形成和血小板减少症的诊断与管理方法。
Med J Aust. 2021 Sep 20;215(6):245-249.e1. doi: 10.5694/mja2.51229. Epub 2021 Sep 6.
10
Acute cerebellar infarction associated with intravenous gammaglobulin treatment in idiopathic thrombocytopenic purpura.特发性血小板减少性紫癜患者行静脉注射免疫球蛋白治疗后并发急性小脑梗死。
J Stroke Cerebrovasc Dis. 2012 Nov;21(8):917.e9-11. doi: 10.1016/j.jstrokecerebrovasdis.2012.05.006. Epub 2012 Jun 29.
引用本文的文献
1
Vaccine-induced immune thrombotic thrombocytopenia: current evidence, potential mechanisms, clinical implications, and future directions.疫苗诱导的免疫性血栓性血小板减少症：当前证据、潜在机制、临床意义及未来方向。
Eur Heart J Open. 2021 Aug 2;1(2):oeab014. doi: 10.1093/ehjopen/oeab014. eCollection 2021 Sep.
2
Prescribing Practices of Intravenous Immunoglobulin in Tertiary Care Hospitals in Malaysia: A Need for a National Guideline for Immunoglobulin Use.马来西亚三级护理医院静脉注射免疫球蛋白的处方实践：需要制定免疫球蛋白使用的国家指南。
Front Pharmacol. 2022 Jun 9;13:879287. doi: 10.3389/fphar.2022.879287. eCollection 2022.
3
COVID-19, Vaccines, and Thrombotic Events: A Narrative Review.2019冠状病毒病、疫苗与血栓形成事件：一篇叙述性综述
J Clin Med. 2022 Feb 11;11(4):948. doi: 10.3390/jcm11040948.
4
A systematic review of vaccine-induced thrombotic thrombocytopenia in individuals who received COVID-19 adenoviral-vector-based vaccines.COVID-19 腺病毒载体疫苗接种者的疫苗诱导性血栓性血小板减少症的系统评价。
J Thromb Thrombolysis. 2022 May;53(4):798-823. doi: 10.1007/s11239-021-02626-w. Epub 2022 Feb 14.
5
SARS-CoV-2 vaccine-induced immune thrombotic thrombocytopenia.SARS-CoV-2 疫苗诱导的免疫性血栓性血小板减少症。
Thromb Res. 2022 Jan;209:75-79. doi: 10.1016/j.thromres.2021.12.002. Epub 2021 Dec 6.
6
Thrombosis in pre- and post-vaccination phase of COVID-19.新型冠状病毒肺炎疫苗接种前和接种后阶段的血栓形成
Eur Heart J Suppl. 2021 Oct 8;23(Suppl E):E184-E188. doi: 10.1093/eurheartj/suab118. eCollection 2021 Oct.
7
Vaccine-induced immune thrombotic thrombocytopenia following AstraZeneca (ChAdOx1 nCOV19) vaccine-A case report.阿斯利康（ChAdOx1 nCOV19）疫苗接种后引发的免疫性血栓性血小板减少症——病例报告
Res Pract Thromb Haemost. 2021 Aug 24;5(6):e12578. doi: 10.1002/rth2.12578. eCollection 2021 Aug.
8
[SARS-CoV-2 vaccines induced immune thrombotic thrombocytopenia].[严重急性呼吸综合征冠状病毒2型疫苗诱导的免疫性血栓性血小板减少症]
Zhonghua Xue Ye Xue Za Zhi. 2021 Jul 14;42(7):607-610. doi: 10.3760/cma.j.issn.0253-2727.2021.07.016.
9
Vaccine-induced immune thrombotic thrombocytopenia after vaccination against Covid-19: A clinical dilemma for clinicians and patients.疫苗接种后 COVID-19 疫苗诱导的免疫性血栓性血小板减少症：临床医生和患者面临的临床难题。
Rev Med Virol. 2022 Mar;32(2):e2273. doi: 10.1002/rmv.2273. Epub 2021 Jul 1.
10
Untangling the Intricacies of Infection, Thrombosis, Vaccination, and Antiphospholipid Antibodies for COVID-19.解析新冠病毒感染、血栓形成、疫苗接种和抗磷脂抗体之间的复杂关系
SN Compr Clin Med. 2021;3(10):2093-2108. doi: 10.1007/s42399-021-00992-3. Epub 2021 Jun 22.
本文引用的文献
1
Thrombocytopenia with acute ischemic stroke and bleeding in a patient newly vaccinated with an adenoviral vector-based COVID-19 vaccine.患者在接种新型冠状病毒病腺病毒载体疫苗后新发血小板减少伴急性缺血性脑卒中及出血。
J Thromb Haemost. 2021 Jul;19(7):1771-1775. doi: 10.1111/jth.15347. Epub 2021 May 5.
2
Successful treatment of vaccine-induced prothrombotic immune thrombocytopenia (VIPIT).成功治疗疫苗诱导的促血栓形成免疫性血小板减少症（VIPIT）。
J Thromb Haemost. 2021 Jul;19(7):1819-1822. doi: 10.1111/jth.15346. Epub 2021 Jun 11.
3
Pathologic Antibodies to Platelet Factor 4 after ChAdOx1 nCoV-19 Vaccination.接种 ChAdOx1 nCoV-19 疫苗后对血小板因子 4 的病理性抗体。
N Engl J Med. 2021 Jun 10;384(23):2202-2211. doi: 10.1056/NEJMoa2105385. Epub 2021 Apr 16.
4
Thrombotic Thrombocytopenia after ChAdOx1 nCov-19 Vaccination.接种 ChAdOx1 nCov-19 疫苗后发生血栓性血小板减少症。
N Engl J Med. 2021 Jun 3;384(22):2092-2101. doi: 10.1056/NEJMoa2104840. Epub 2021 Apr 9.
5
Thrombosis and Thrombocytopenia after ChAdOx1 nCoV-19 Vaccination.ChAdOx1新冠疫苗接种后的血栓形成和血小板减少症
N Engl J Med. 2021 Jun 3;384(22):2124-2130. doi: 10.1056/NEJMoa2104882. Epub 2021 Apr 9.
6
No SARS-CoV-2 Neutralization by Intravenous Immunoglobulins Produced From Plasma Collected Before the 2020 Pandemic.静脉注射用免疫球蛋白无法中和 2020 年大流行前采集的血浆中分离的 SARS-CoV-2。
J Infect Dis. 2020 Nov 13;222(12):1960-1964. doi: 10.1093/infdis/jiaa593.
7
Prevalence of Zika virus neutralizing antibodies in healthy adults in Vietnam during and after the Zika virus epidemic season: a longitudinal population-based survey.寨卡病毒流行期间和流行季节过后越南健康成年人中寨卡病毒中和抗体的流行情况：一项基于人群的纵向调查。
BMC Infect Dis. 2020 May 11;20(1):332. doi: 10.1186/s12879-020-05042-2.
8
Does intravenous immunoglobulin therapy in Guillain-Barré syndrome patients interfere with serological Zika detection?
Autoimmun Rev. 2019 Jun;18(6):632-633. doi: 10.1016/j.autrev.2019.01.004. Epub 2019 Apr 5.
9
IVIG-mediated effector functions in autoimmune and inflammatory diseases.静脉注射免疫球蛋白在自身免疫和炎症性疾病中的效应功能。
Int Immunol. 2017 Dec 30;29(11):491-498. doi: 10.1093/intimm/dxx039.
Zotero 插件